Author

E. M. Campbell

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 4 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Organism:mouse· 1

Frequent Co-Authors

J. Luban· 2 shared K. Kim· 2 shared A. Dauphin· 1 shared A. Felton· 1 shared A. R. Cannon· 1 shared C. Carbone· 1 shared C. R. Aiken· 1 shared C. Strambio-De-Castillia· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

J. Luban

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

HIV-1 binds dynein directly to hijack microtubule transport machinery

S. Badieyan, D. Lichon, M. P. Andreas, J. P. Gillies, W. Peng, J. Shi, M. E. DeSantis, C. R. Aiken, T. Böcking, T. W. Giessen, E. M. Campbell, M. A. Cianfrocco

This study shows HIV-1 directly binds dynein to hijack microtubule transport for motility, bypassing traditional cargo adaptors.

bioRxiv · Aug 29, 2023Microbiology

DSS-induced inflammation in the colon drives a pro-inflammatory signature in the brain that is ameliorated by prophylactic treatment with the S100A9 inhibitor paquinimod

S. Talley, R. Valiauga, L. Anderson, A. R. Cannon, M. A. Choudhry, E. M. Campbell

This study shows that colonic inflammation from DSS induces a pro-inflammatory brain signature, which is reduced by S100A9 inhibitor paquinimod.

bioRxiv · Sep 22, 2021 · PreprintImmunology

TRIM34 acts with TRIM5 to restrict HIV and SIV capsids

M. Ohainle, K. Kim, S. Keceli, A. Felton, E. M. Campbell, J. Luban, M. Emerman

This study identifies TRIM34 as an HIV-1 capsid-targeting restriction factor that acts with TRIM5alpha to restrict HIV and SIV infection during reverse transcription.

bioRxiv · Oct 30, 2019 · PreprintMicrobiology

Cyclophilin A protects HIV-1 from restriction by human TRIM5α

K. Kim, A. Dauphin, S. Komurlu, L. Yurkovetskiy, W. E. Diehl, S. M. McCauley, C. Carbone, C. Strambio-De-Castillia, E. M. Campbell, J. Luban

This study shows that Cyclophilin A protects HIV-1 from restriction by human TRIM5α by shielding the viral capsid from early inhibition during infection.

bioRxiv · Aug 24, 2019Microbiology